Investors

29 May 2025

Biochip integrates with readout circuitry on a silicon chip

→

19 May 2025

Archer partners with Paragraf for Biochip development

→

12 May 2025

Partnership extended with QMUL

→

07 May 2025

Presentation - Semiconductor Conference 2025

→

05 May 2025

Appointment of Company Secretary

→

16 April 2025

Quarterly Activity Report & Appendix 4C

→

09 April 2025

12CQ Quantum Program Presentation - RMIT Quantum Industry Day

→

31 March 2025

AXE partners with Hylid Diagnostics for Biochip development

→

27 March 2025

Appointment of Chief Executive Officer

→

26 February 2025

Appendix 4D and Half Year Financial Report

→

25 February 2025

Improved Biochip Accuracy Paves Way for Human Blood Testing

→

13 February 2025

Precision spin state control for next-generation qubits

→

22 January 2025

Archer Granted Key Biochip Patent

→

17 January 2025

Quarterly Activity Report & Appendix 4C

→

08 January 2025

Breakthrough in Quantum Carbon Films for Qubit Realisation

→

16 December 2024

Response to ASX Price Query Letter

→

02 December 2024

Change in substantial holding from AXE

→

28 November 2024

Biochip moves toward feasibility & improved testing accuracy

→

27 November 2024

Archer receives $2.1 million R&D Tax Incentive rebate

→

25 November 2024

Archer receives prototype TMR sensors from foundry partner

→